… and of Plasmodium vivax in particular. Even for malariologists steeped in an understanding
of the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum, P. vivax …

… burden, as well as severe, lethal, and chloroquine-resistant vivax malaria to demonstrate that
… Plasmodium vivax in mixed infections is also often underdiagnosed 48 ; lower densities of …

… Population studies from many parts of the world have shown that individuals exposed to
multiple infections and experienced clinical episodes of P vivax or P. falciparum acquires …

… vivax infections inferred from therapeutic efficacy studies and clinical trials. We note that
the limited available data from ex-vivo sensitivity assays do not provide a geographically …

… Emerging resistance to chloroquine (CQ) by Plasmodium vivax threatens the health of the
hundreds of millions of people routinely exposed to the risk of infection with this organism. CQ …

… American blacks, who are the only groups completely resistant to infection by P. vivax. To
determine if the FyFy genotype is the vivax resistance factor, we performed blood typing on 11 …

… seven days is the treatment of choice of infections by Plasmodium vivax in Bolivia, where 95%
of the … In conclusion, 6.5% of resistance to CQ was observed in infections by P. vivax in the …

… We address the role of antibody-mediated resistance to P. vivax infection and discuss current
progress in vaccine development. Finally, we review immunoregulatory mechanisms, such …

… P vivax malaria treatment efficacy studies to establish the global extent of chloroquine
resistance… We determined rates of chloroquine resistance according to P vivax malaria recurrence …

… Plasmodium falciparum infection exerts a considerable burden on pregnant women, but
less is known about the adverse consequences of Plasmodium vivax infection. …